Examinant per Autoria "Llombart-Cussac, Antonio"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer(Elsevier, 2024) Di Cosimo, Serena; Albanell Mestres, Joan; Llombart-Cussac, Antonio
Ítem Accés Obert Palbociclib rechallenge for hormone receptor-positive/HER-negative advanced breast cancer: findings from the phase II BioPER trial(American Association for Cancer Research (AACR), 2023) Albanell Mestres, Joan; Comerma Blesa, Laura, 1983-; Gibert, Joan; Bellosillo Paricio, Beatriz; Menéndez, Silvia; Llombart-Cussac, Antonio
Ítem Accés Obert Palbociclib with fulvestrant or letrozole in endocrine-sensitive patients with HR-Positive/HER2-Negative advanced breast cancer: A detailed safety analysis of the randomized PARSIFAL trial(Oxford University Press, 2023) Di Cosmo, Serena; Albanell Mestres, Joan; Llombart-Cussac, Antonio
Ítem Accés Obert Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: the DEBBRAH trial(Oxford University Press, 2023) Pérez-García, José Manuel; Vaz Batista, Marta; Cortez, Patricia; Ruiz-Borrego, Manuel; Cejalvo, Juan Miguel; de la Haba-Rodríguez, Juan; Garrigós, Laia; Racca,Fabricio; Servitja Tormo, Sonia; Blanch, Salvador; Gion, María; Nave, Monica; Fernández-Abad, María; Martínez-Bueno, Alejandro; Llombart-Cussac, Antonio; Sampayo-Cordero, Miguel; Malfettone, Andrea; Cortés, Javier; Braga, Sofía